Latest Breaking News On - Exchange regulation - Page 6 : comparemela.com

Cosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023

Cosmo Pharmaceuticals N.V. today announced that the company has been granted extension until 31 May 2024 to publish its 2023 annual report and to file such report with SIX Exchange Regulation.

Hazel winchesterCosmo pharmaceuticalsExchange regulationIreland newsfile corpListing rulesInvestor relations

Cosmo Pharmaceuticals N V : Cosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023

Cosmo Pharmaceuticals N V : Cosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis riedlHazel winchesterExchange regulationIreland newsfile corpCosmo pharmaceuticalsListing rulesAktien sie

Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 25, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May 2023 financial key figures: Revenue from contracts with customers of CHF 103.4 million (2022: CHF 7.5 million) Net result of CHF 54.8 million (2022: CHF -71.1 million) Cash flow from operating

United statesUnited kingdomSwitzerland generalShabir hashamDario eklundAndrew smithEva kaliasChiesi farmaceuticiAmerica to catalyst pharmaceuticals incLife science allianceNational institute for healthSanthera pharmaceuticals holdingCatalyst pharmaceuticals incExchange regulation ltdRegulatory agencySanthera pharmaceuticals holding ltd

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomSwitzerland generalUnited statesDennis riedlEva kaliasDario eklundShabir hashamChiesi farmaceuticiAndrew smithSanthera pharmaceuticalsChina national medical products administrationCatalyst pharmaceuticalsHead investor relations communicationsExchange regulationEuropean medicines agencyEuropean union summary of product characteristics

Feintool general meeting approves all motions

This is an ad hoc announcement pursuant to Article 53 of the Listing Rules of the SIX Exchange Regulation AG. The shareholders of Feintool International Holding AG accepted all motions at the Annual.

Switzerland generalUnited statesKarin labhartNorbert indlekoferHeinz loosliMarcus bolligExchange regulationGroup executive board of the artemisGroup executive boardCompensation committeeFeintool international holdingArtemis groupListing rulesAnnual general meetingExecutive committeeGeneral meeting